(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain medication that’s just been approved by the FDA. Suzetrigine is the first ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...

The American Society of Anesthesiologists is urging CMS not to proceed with proposed policies that would end coverage of peripheral nerve blocks for chronic pain. ASA applauded 25 bipartisan members ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

A new drug is providing hope for patients with severe or moderate acute pain, offering an alternative that is designed to be less harmful than opioids. The drug, called Journavx, is part of a broader ...

Add Yahoo as a preferred source to see more of our stories on Google. Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, which ...

Global pain market seeks non-opioid drugs, digital tools and novel targets as generics dominate and trial challenges slow ...

A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

A person whose doctor wanted to try a non-opioid medication after surgery – exactly the kind of acute pain situation these drugs are approved for.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill received ...